Abstract
The LP-BM5 mixture of murine retroviruses elicits a disease in mice referred to as murine immunodeficiency syndrome (MAIDS) that is considered by some to be an animal homologue of human AIDS. In this article, we present and discuss some recent findings on the pathogenesis of the murine disease and their implications for the proposed homology between murine and human syndromes. The murine disease seems to display as many similarities to as it does differences from human AIDS. Among the latter are: definitive and exclusive viral etiology, a strong genetic effect on susceptibility to infection, expansion of the CD4+ cell population in spleen and peripheral blood, consistent transmissibility by a single transfusion of the minute amounts of blood or plasma from infected donors, and striking similarity between virus-induced alteration of the in vitro spleen cell proliferation and those caused by treatment with a protein kinase inhibitor K252a. With this in mind, the use of the noncommittal term retrovirus-induced murine lymphoproliferative disease instead of MAIDS appears to be more appropriate at this time.
Similar content being viewed by others
References
Warth JA: The risk of development of AIDS in hemophiliac and homosexual men. JAMA 1989;262:3129–3130.
Root-Bernstein RS: Rethinking AIDS: The Tragic Cost of Premature Consensus. New York. Free Press, 1993.
Breimer LH: Did Moritz Kaposi describe AIDS in 1872? Clio Med 1984;19:156–159.
Ellis FA: Multiple idiopathic hemorrhagic sarcoma of Kaposi. Arch Dermatol Syphilis 1934;30:706–708.
Collins MD, Fisher H: A case of generalized hemangiosarcoma erroneously considered as generalized tuberculosis. Am Rev Tuberc 1950;61:257–262.
Moore JD, Cone EJ, Alexander SS Jr: HTLV-III seropositivity in 1971–72: Parenteral drug abusers—a case of false positives or evidence of viral exposure. N Engl J Med 1985;314:1387–1388.
Lemaitre M, Guetard D, Henin Y, Montagnier L, Zerial A: Protective activity of tetracycline 3 analogs against cytopathic effect of the human immundeficiency virus in CEM cells. Res Virol 1990;141:5–16.
Lo S-C, Hayes MN, Wang RY-H, Pierce PF, Kotani H, Shih JW-K: Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 1991;338:1415–1418.
Zagury D, Bernard J, Leibowitch J, Safari B, Groopman JE, Feldman M, Sarngadharn MG, Gallo RC: HTLV-III in cells cultured from semen of two patients with AIDS. Science 1984;226:449–451
Levy J: The transmission of AIDS: The case of the infected cells. JAMA 1988;259:3037–3038.
Chiasson MA, Stonebruer RL, Joseph SC: Human immunodeficiency virus transmission through artificial insemination. J AIDS 1990;3:69–72.
Garland FC, Mayers DL, Hickey TM, Miller MR, Shaw EK, Gorham ED, Bigbee LR, McNally MM: Incidence of human immunodeficiency virus seroconversion in US Navy and Marine Corps personnel: 1986–1988. JAMA 1989;262:3161–3165.
Sonnex C: Transient antibody to human immunodeficiency virus. Ann Intern Med 1986;105:464–465.
Luca Moretti M: Specific behavioral factors among intravenous drug users have been shown to influence HIV seroconversion, and behavioral modification among HIV seroconverted former intravenous drug users have been shown to delay the onset of AIDS, ARC and AIDS related diseases. J InterAm Med Health Assoc 1992;1:1–8.
Pankhurst C, Peaknol M: Reduced CD4+ cells and severe oral candidiasis in the absence of HIV infection. Lancet 1989;i:672.
Hoffman OW, Kion TA, Orant MD: An idiotypic network model for AIDS pathogenesis. Proc Natl Acad Sci USA 1990;88:3060–3064
Root-Bernstein RS, Hobbs SH: Homologies between mycoplasma adhesion peptide, CD4+, and class II MHC protein: Possible mechanisms for HIV-mycoplasma synergism in AIDS. Res Immunol 1991;142:519–523.
Fultz PN, McClure HM, Swenson RB: Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: A potential model for acquired immunodeficiency syndrome. J Virol 1986;58:116–124.
Kulaga H, Folks T, Rutledge R: Infection of rabbits with human immunodeficiency virus I. J Exp Med 1989;169:321–326.
Mosier DE: Animal models for retrovirus-induced immunodeficiency disease. Immunol Invest 1986;15:233–261.
Mosier DE, Yetter RA, Morse HC III: Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J Exp Med 1985;161:766–784.
Thacore HR, Cunnigham RK, Zhou P, Nakeeb S, Terzian R, Zaleski MB: Acquired immunodeficiency in murine lymphoproliferative disease: Consideration on pathogenesis. Immunobiology, 1994;190:195–211.
Cunnigham RK, Thacore HR, Zhou P, Nakeeb S, Zaleski MB: Blood transfusion as a means for transmission of retrovirus-induced lymphoproliferative disease in mice. Int Arch Allergy Immunol 1994;103:16–22.
Jerne NK, Nordin AA: Plaque formation in agar by single antibody producing cell. Science 1963;140:405.
Portales P, Rojo J, Golby A: Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T-cell activation. J Immunol 1989;142:4169–4175.
Cunnigham RK, Zhou P, Zaleski MB: Postnatal development of murine spleen cell proliferative responses to interleukin 2 or phorbol ester and calcium ionophore A23187. Immunobiology 1991;184:53–62.
Chattopadhyay SK, Sengupta DN, Fredrickson TN: Characteristics and contributions of defective, ecotropic and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J Virol 1991;65:4232–4241.
Hugin AW, Vacchio MS, Morse HC, III A virus-encoded ‘superantigen’ in a retrovirus-induced immunodeficiency syndrome of mice. Science 1991;252:424–427.
Zhou P, Quackenbush LJ, Albini B, Zaleski MB: In vitro proliferation of murine spleen cells: Genetic control of proliferative responses induced by phorbol ester and calcium ionophore A23187. Immunobiology 1989;180:55–67.
Truneh A, Albert F, Goldstein P, Schmitt-Verhulst AM: Early steps of lymphocyte activation by-passed by calcium ionophore and phorbol ester acting in synergy. Nature 1985; 313:318–320.
Rudd CE: CD4, CD8 and the TCR-CD3 complex: A novel class of protein-tyrosine kinase receptor. Immunol Today 1990;11:400–405.
Kase H, Iwashi K, Nakanishi S: M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 1987;142:436–440.
Zemabala M, Pryjma J, Plucienniczak A, Szczepanek A, Ruggiero I, Jasinski M, Colizzi V: Modulation of antigen presenting capacity of human monocytes by HIV-1 GP 120 molecule fragments. Immunol Invest, 1994;23:189–199.
Zaleski M, Milgrom F: The suppressive effect of graft-versus-host reaction (GVHR) on the immune response of mice to O AKR antigen. Exp Hematol 1973;1:80.
Okada Y, Suzuki K, Komouro K, Mizouchi T: High frequency of transmission of murine AIDS virus in C57BL/10 mice via mother’s milk. J Virol 1992;66:5177–5182.
Schwartz DH: Potential pitfalls on the road to an effective HIV vaccine. Immunol Today 1994;15:54–57.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cunnigham, R.K., Thacore, H.R., Zhou, P. et al. Murine AIDS: A model for the human disease or a distinct entity?. Immunol Res 13, 21–28 (1994). https://doi.org/10.1007/BF02918221
Issue Date:
DOI: https://doi.org/10.1007/BF02918221